MARATTO

article · Journal of drug targeting

A Dual-Action nanoemulsified mucoadhesive polymeric buccal film of curcumin–lidocaine: non-Invasive targeting oral mucositis treatment via MMP-9 and NF-κβ pathways

Abstract

, the CUR-LID film significantly enhanced ulcer healing (∼95-100% by day 5), with complete mucosal regeneration and normalisation of inflammatory biomarkers to baseline levels. This work supports the CUR-LID buccal film as a prospective non-invasive platform for managing oral mucositis with better therapeutic outcomes, effective drug delivery, and prolonged mucosal contact.

Research topics

  • Oral health in cancer treatment
  • Advanced Drug Delivery Systems
  • Bone health and treatments

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/1061186x.2026.2613056

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.